ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,537
Screening encounters
2,803
Diagnostic referrals
540
Outstanding pathways
216

Screening pathway

  1. Screening2,803Encounters
  2. Positive finding945Documented findings
  3. Referral540Diagnostic referrals
  4. Follow-up626Diagnostic visits
  5. Outcome324Resolved pathways

Stage totals use different units. Pending pathways: 216. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1102 · EXP-1102Synthetic · Site B

Full participant history through 2026-03-27, across modalities and pathways.

  1. · Screening · Cytology · Initial · Programme entry
  2. · Screening result · Cytology · NILM · Adequate

Referral-time risk

No matching referral was available at this observation date.

Screened participants

2537 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2002 · Expanded synthetic participant 2002Site E — Resource-Constrained Navigation Programme
EXP-2004 · Expanded synthetic participant 2004Site E — Resource-Constrained Navigation Programme
EXP-2006 · Expanded synthetic participant 2006Site B — Peri-Urban Access Programme
EXP-2008 · Expanded synthetic participant 2008Site B — Peri-Urban Access Programme
EXP-2009 · Expanded synthetic participant 2009Site B — Peri-Urban Access Programme
EXP-2010 · Expanded synthetic participant 2010Site B — Peri-Urban Access Programme
EXP-2012 · Expanded synthetic participant 2012Site B — Peri-Urban Access Programme
EXP-2014 · Expanded synthetic participant 2014Site E — Resource-Constrained Navigation Programme
EXP-2016 · Expanded synthetic participant 2016Site B — Peri-Urban Access Programme
EXP-2019 · Expanded synthetic participant 2019Site C — Rural Outreach Programme
EXP-2020 · Expanded synthetic participant 2020Site E — Resource-Constrained Navigation Programme
EXP-2021 · Expanded synthetic participant 2021Site C — Rural Outreach Programme
EXP-2022 · Expanded synthetic participant 2022Site D — Community Engagement Programme
EXP-2026 · Expanded synthetic participant 2026Site B — Peri-Urban Access Programme
EXP-2028 · Expanded synthetic participant 2028Site B — Peri-Urban Access Programme
EXP-2029 · Expanded synthetic participant 2029Site D — Community Engagement Programme
EXP-2030 · Expanded synthetic participant 2030Site E — Resource-Constrained Navigation Programme
EXP-2032 · Expanded synthetic participant 2032Site B — Peri-Urban Access Programme
EXP-2034 · Expanded synthetic participant 2034Site B — Peri-Urban Access Programme
EXP-2035 · Expanded synthetic participant 2035Site C — Rural Outreach Programme
EXP-2036 · Expanded synthetic participant 2036Site D — Community Engagement Programme
EXP-2037 · Expanded synthetic participant 2037Site B — Peri-Urban Access Programme
EXP-2040 · Expanded synthetic participant 2040Site C — Rural Outreach Programme
EXP-2041 · Expanded synthetic participant 2041Site D — Community Engagement Programme
EXP-2047 · Expanded synthetic participant 2047Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1162
HPV DNA
1223
Cytology
418

Navigation activity

Barrier documented
458
Contact attempt
787
Navigation intervention
193
Diagnostic booking
663
Diagnostic visit
626

Documented barriers

Contact difficulty
146
Transport difficulty
144
Appointment coordination
168

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.